Barbara A. Wiesinger

1.1k total citations
12 papers, 838 citations indexed

About

Barbara A. Wiesinger is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Barbara A. Wiesinger has authored 12 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Pharmacology and 2 papers in Infectious Diseases. Recurrent topics in Barbara A. Wiesinger's work include Pneumonia and Respiratory Infections (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Barbara A. Wiesinger is often cited by papers focused on Pneumonia and Respiratory Infections (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Barbara A. Wiesinger collaborates with scholars based in United States. Barbara A. Wiesinger's co-authors include James B. Kahn, Alan M. Tennenberg, Neringa Zadeikis, Jim Xiang, Richard G. Wunderink, Lala M. Dunbar, Michael P. Habib, Leon G. Smith, Mohammed M. Khashab and Shu‐Chen Wu and has published in prestigious journals such as Clinical Infectious Diseases, Urology and Clinical Therapeutics.

In The Last Decade

Barbara A. Wiesinger

12 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara A. Wiesinger United States	10	666	284	197	183	132	12	838
Neringa Zadeikis United States	8	432 0.6×	181 0.6×	47 0.2×	135 0.7×	116 0.9×	9	579
Juan García-de-Lomas Spain	13	667 1.0×	200 0.7×	242 1.2×	161 0.9×	43 0.3×	17	886
Alan T. Evangelista United States	13	565 0.8×	283 1.0×	119 0.6×	242 1.3×	40 0.3×	27	759
Claudette Muller‐Serieys France	18	335 0.5×	255 0.9×	197 1.0×	337 1.8×	71 0.5×	40	806
Jin Seo Lee South Korea	15	307 0.5×	62 0.2×	152 0.8×	142 0.8×	104 0.8×	47	661
Laura Folgori Italy	16	290 0.4×	122 0.4×	111 0.6×	187 1.0×	62 0.5×	36	688
Sang Yop Shin South Korea	14	365 0.5×	128 0.5×	87 0.4×	464 2.5×	58 0.4×	36	848
P Aswapokee United States	10	275 0.4×	407 1.4×	115 0.6×	332 1.8×	168 1.3×	19	773
A. Voss Spain	9	339 0.5×	69 0.2×	132 0.7×	269 1.5×	76 0.6×	12	644
Abel Jasovich Argentina	10	211 0.3×	226 0.8×	76 0.4×	202 1.1×	40 0.3×	22	439

Countries citing papers authored by Barbara A. Wiesinger

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Wiesinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Wiesinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Wiesinger more than expected).

Fields of papers citing papers by Barbara A. Wiesinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Wiesinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Wiesinger. The network helps show where Barbara A. Wiesinger may publish in the future.

Co-authorship network of co-authors of Barbara A. Wiesinger

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Wiesinger. A scholar is included among the top collaborators of Barbara A. Wiesinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Wiesinger. Barbara A. Wiesinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kahn, James B., et al.. (2004). Cumulative Clinical Trial Experience with Levofloxacin for Patients with Community-Acquired Pneumonia-Associated Pneumococcal Bacteremia. Clinical Infectious Diseases. 38(Supplement_1). S34–S42. 11 indexed citations

Wiesinger, Barbara A., et al.. (2004). Acute Community‐Acquired Bacterial Sinusitis: The Value of Antimicrobial Treatment and the Natural History. Clinical Infectious Diseases. 38(2). 227–233. 47 indexed citations

Akpunonu, Basil, et al.. (2004). Multicenter, Postmarketing Assessment of Levofloxacin in the Treatment of Adults with Community-Acquired Pneumonia. Clinical Infectious Diseases. 38(Supplement_1). S5–S15. 17 indexed citations

Kahn, James B., Barbara A. Wiesinger, & Jim Xiang. (2004). Macrolide-Resistant Streptococcus pneumoniae in Community-Acquired Pneumonia: Clinical and Microbiological Outcomes for Patients Treated with Levofloxacin. Clinical Infectious Diseases. 38(Supplement_1). S24–S33. 7 indexed citations

Fogarty, Charles, Ghodrat A. Siami, Richard Köhler, et al.. (2004). Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of Levofloxacin versus Ceftriaxone Sodium and Erythromycin Followed by Clarithromycin and Amoxicillin- Clavulanate in the Treatment of Serious Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases. 38(Supplement_1). S16–S23. 45 indexed citations

West, Mike, Bernard R. Boulanger, Charles Fogarty, et al.. (2003). Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study. Clinical Therapeutics. 25(2). 485–506. 89 indexed citations

Ray, Paul S., William M. Schiff, Alan M. Tennenberg, et al.. (2003). Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology. 62(3). 537–541. 92 indexed citations

Dunbar, Lala M., Richard G. Wunderink, Michael P. Habib, et al.. (2003). High‐Dose, Short‐Course Levofloxacin for Community‐Acquired Pneumonia: A New Treatment Paradigm. Clinical Infectious Diseases. 37(6). 752–760. 250 indexed citations

Liu, Jing, Gary T. Kinasewitz, Gregory J. Moran, et al.. (2002). A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. Clinical Therapeutics. 24(8). 1292–1308. 74 indexed citations

10.

Hassell, Alan E., Peter P. Lee, Honghui Zhou, et al.. (1999). Lack of Effect of Erythromycin and Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Steady‐State Intranasal Levocabastine. The Journal of Clinical Pharmacology. 39(1). 76–85. 8 indexed citations

11.

Saag, Michael S., Gretchen A. Cloud, John R. Graybill, et al.. (1999). A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS‐Associated Cryptococcal Meningitis. Clinical Infectious Diseases. 28(2). 291–296. 157 indexed citations

12.

Adelglass, Jeffrey, Terry M. Jones, Gary Ruoff, et al.. (1998). A Multicenter, Investigator‐Blinded, Randomized Comparison of Oral Levofloxacin and Oral Clarithromycin in the Treatment of Acute Bacterial Sinusitis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(6). 1255–1263. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact